The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What is the news about ropeginterferon?

Sep 10, 2020
Share:

During the First Annual Texas Virtual MPN Workshop, the MPN Hub spoke to our Steering Committee Chair, Jean-Jacques Kiladjian, Université de Paris, Paris, FR, about ropeginterferon alfa-2b. This is a recently approved, new-generation interferon treatment for patients with polycythemia vera (PV).

What is the news about ropeginterferon?

In this video, Jean-Jacques Kiladjian discusses the results of recent trials with ropeginterferon, including the 4-year results of the PROUD-PV and CONTINUATION-PV studies, which were the registration trials for ropeginterferon. He also discusses the new results from Prof Tiziano Barbui and the LOW-PV trial.

Share: